← Back to Search

Physical Therapy Device

1 for Pediatric Asthma Exacerbation

N/A
Waitlist Available
Led By Adaobi C Kanu, MD
Research Sponsored by Texas Tech University Health Sciences Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
2 to 21 yo (VEST approved for over two yo) Admitted to PICU for status asthmaticus Negative urine pregnancy test prior to initiation of study in those with menses
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up days
Awards & highlights

Study Summary

Asthma is a disease resulting in mucus hypersecretion and airways obstruction. This causes difficulty breathing. The High Frequency Chest Compressor (HFCC) is a device that has been shown to decrease respiratory complications in individuals with severe disability who are unable to clear airway secretions. There is a lack of studies using this device in children with asthma. The device has been shown in a study to be safe in children with asthma. The investigators propose that using this device in our pediatric patients hospitalized in the pediatric ICU with asthma will result in decreased pediatric ICU stay. The investigators will also look at asthma severity, total days of hospital stay and chest discomfort while on therapy.

Eligible Conditions
  • Pediatric Asthma Exacerbation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~number of hours from admission to discharge from picu
This trial's timeline: 3 weeks for screening, Varies for treatment, and number of hours from admission to discharge from picu for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hours Spent in Pediatric ICU
Secondary outcome measures
Number of Participants With Chest Discomfort
Pediatric Asthma Severity Score (Modified Pulmonary Index Score)
Total Days of Hospital Admission

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Use of the HFCC device in addition to standard therapy for status asthmaticus. The use of HFCC will not affect the therapy received
Group II: 2Active Control1 Intervention
This group will not use the VEST or HFCC. They will just have standard therapy for status asthmaticus. The standard therapy will not be affected if they are in this group.

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences CenterLead Sponsor
104 Previous Clinical Trials
10,738 Total Patients Enrolled
Adaobi C Kanu, MDPrincipal InvestigatorTexas Tech University Health Sciences Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Use of High Frequency Chest Compression in Pediatric Status Asthmaticus
2007. "Use of High Frequency Chest Compression in Pediatric Status Asthmaticus". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00552448.
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top